Bubble Intelligence

Market Intelligence For The New Regime

Moderna, Inc.
MRNAmodernatx.com
Latest Filing: May 1, 2026 • 25 Total Filings
Total Assets
2026
$11.49B
Total Revenue
2026
$389.00M
Net Income
2026
$-1.34B
Operating Cash Flow
2026
$-630.00M
Filing Year:
2025
Only 2025 data available
Data Source:
Showing data from all document types
Filters:
located inlocated inlocated inlocated incompetes withcompetes withcompetes withcompetes withcompetes withcompetes with
Moderna, Inc.
Ticker: MRNA
Unknown Region
4 suppliers
Cellscript, LLC
ip_licensor
⚠ Critical
mRNA RiboTherapeutics, Inc.
ip_licensor
⚠ Critical
National Institute of Allergy and Infectious Diseases
ip_licensor
Novocol Pharma
contract_manufacturer
BioNTech
GSK
Pfizer
Sanofi
COVID vaccines
Major Competitor
Novavax
COVID vaccines
Major Competitor
GlaxoSmithKline
RSV vaccines
Major Competitor
React Flow
Legend:
Company
Critical Supplier
Significant Supplier
Standard Supplier
Major Competitor
Emerging Competitor
Competitor
Regional Supplier Concentration
0 regions with known supplier geography · 4 suppliers without location data
Risk:LowModerateElevatedHigh
4 suppliers · no geography